Your browser doesn't support javascript.
loading
miR-1293 Suppresses Tumor Malignancy by Targeting Hydrocyanic Oxidase 2: Therapeutic Potential of a miR-1293/Hydrocyanic Oxidase 2 Axis in Renal Cell Carcinoma.
Liu, Xiao-Li; Pan, Wen-Gu; Li, Kai-Lin; Mao, Yi-Jie; Liu, Shuang-De; Zhang, Rong-Mei.
Afiliação
  • Liu XL; Department of Kidney Transplantation and The Second Hospital, Shandong University, Jinan, People's Republic of China.
  • Pan WG; Department of Kidney Transplantation and The Second Hospital, Shandong University, Jinan, People's Republic of China.
  • Li KL; Department of Central Research Lab, The Second Hospital, Shandong University, Jinan, People's Republic of China.
  • Mao YJ; Department of Kidney Transplantation and The Second Hospital, Shandong University, Jinan, People's Republic of China.
  • Liu SD; Department of Kidney Transplantation and The Second Hospital, Shandong University, Jinan, People's Republic of China.
  • Zhang RM; Department of Kidney Transplantation and The Second Hospital, Shandong University, Jinan, People's Republic of China.
Cancer Biother Radiopharm ; 35(5): 377-386, 2020 Jun.
Article em En | MEDLINE | ID: mdl-31971830

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Antineoplásicos Alquilantes / MicroRNAs / Oxirredutases do Álcool / Neoplasias Renais Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Antineoplásicos Alquilantes / MicroRNAs / Oxirredutases do Álcool / Neoplasias Renais Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article